GIM
BSX icon

Glenmede Investment Management’s Boston Scientific BSX Stock Holding History

Glenmede Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.67M Buy
99,081
+77,375
+356% +$8.01M 0.05% 359
2025
Q2 		$2.33M Buy
+21,706
New +$2.2M 0.01% 542

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glenmede Investment Management's BSX Position: Q3 2025 in Review

Glenmede Investment Management increased its Boston Scientific (BSX) stake by 356% in Q3 2025, buying an estimated $8.01M and bringing the position to 99,081 shares worth $9.67M. The position accounts for 0.05% of the portfolio, ranked #359.

Glenmede Investment Management first reported a position in BSX in Q2 2025 and has held it in 2 quarters since. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Glenmede Investment Management held 99,081 shares of Boston Scientific worth $9.67M as of Q3 2025.
  • Glenmede Investment Management bought 77,375 Boston Scientific shares in Q3 2025, an estimated $8.01M.
  • Boston Scientific made up 0.05% of Glenmede Investment Management's portfolio in Q3 2025, its #359 holding.
  • Glenmede Investment Management first reported a position in Boston Scientific in Q2 2025 and has held it in 2 quarters since.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.